HOISINGTON — Clara Barton Medical Center announced the appointment of Amanda (Mandy) Hoffman as interim CEO, marking a new phase of leadership. With a strong background within the organization, Hoffman’s promotion brings stability and confidence to Clara Barton Medical Center. Her extensive experience and unwavering commitment make her well-prepared to lead the organization into a promising new chapter.

With a Bachelor of Science in Biology/Chemistry from the University of Saint Mary and a PharmD from the University of Kansas School of Pharmacy, Hoffman brings a solid foundation of knowledge and expertise to her role as interim CEO. Her extensive experience working in both hospital and retail pharmacy settings, coupled with her years of service at Clara Barton Medical Center, have provided her with a comprehensive understanding of the health-care landscape and the unique needs of the organization.

Starting at Clara Barton as a staff Pharmacist in 2012, Hoffman quickly rose through the ranks as she was promoted to Director of Pharmacy in 2018 and later promoted to VP/Chief Operating Officer in 2020.

“Mandy’s promotion to interim CEO reflects her exceptional contributions and unwavering dedication to Clara Barton Medical Center over the past eleven years,” said Kathy Kaiser, Clara Barton Hospital Board president. “From her role as director of pharmacy, she swiftly implemented innovative strategies and showcased a deep commitment to delivering quality health-care services to our community. Mandy’s unwavering drive and exemplary leadership make her the ideal fit for the interim CEO position.”

Hoffman’s promotion will provide a seamless transition and ensure the preservation of Clara Barton Medical Center’s strong culture of customer service and patient care, Kaiser said. Hoffman’s vision for the future will help Clara Barton Medical Center adapt to the ever-changing health-care industry while maintaining its commitment to delivering exceptional care to the community.